Efficacy of Navakarshik Guggul in Sheetpitta

Randomized control clinical trial of Navakarshik Guggul in Sheetpitta

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023949

Enrollment

Registered

2020-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

Intervention1: Navakarshik Guggul in Sheetpitta: Navakarshik Guggul 500 mg BD along with Koshna Jala for 14 days. Control Intervention1: Trikatu Churna: Trikatu Churna 500mg BD with Sharkara for 14 da

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical signs and symptoms of Sheetpitta- Mandal,Kandu,Toda,Daha,Jwar,Chhardi will included in study.

Exclusion criteria

Exclusion criteria: 1.Patients prediagnosed as DM,Psoriasis,Eczema. 2.History of allergic to medicine. 3.Pregnant and lactating mother.

Design outcomes

Primary

Measure	Time frame
To determine the efficacy of Navakarshik Guggul in SheetpittaTimepoint: 24weeks	—

Secondary

Measure	Time frame
To review literature on SheetpittaTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactPratiksha Gopal Kolekar

Hon Shri Annasaheb Dange Ayurved Medical College And Post Graduate Research Training Center Ashta

pdeshmukhe@yahoo.co.in7719954457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026